Cibc World Market Inc. acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 21,796 shares of the company’s stock, valued at approximately $10,528,000.
Several other institutional investors and hedge funds have also made changes to their positions in the business. Royal Bank of Canada grew its holdings in shares of Astera Labs by 167.3% in the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after purchasing an additional 95,409 shares during the last quarter. AQR Capital Management LLC lifted its holdings in Astera Labs by 213.4% during the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock valued at $680,000 after buying an additional 7,756 shares in the last quarter. Empowered Funds LLC lifted its holdings in Astera Labs by 917.3% during the 1st quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock valued at $277,000 after buying an additional 4,183 shares in the last quarter. First Trust Advisors LP boosted its position in Astera Labs by 102.0% in the 2nd quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock valued at $10,196,000 after buying an additional 56,952 shares during the period. Finally, Brown Advisory Inc. boosted its position in Astera Labs by 54.9% in the 2nd quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock valued at $505,000 after buying an additional 1,977 shares during the period. 60.47% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
ALAB has been the subject of several research analyst reports. Citigroup reaffirmed a “buy” rating on shares of Astera Labs in a research note on Wednesday, July 29th. Royal Bank Of Canada increased their price target on Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 5th. JPMorgan Chase & Co. raised their price target on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Evercore restated an “outperform” rating and issued a $297.00 price objective on shares of Astera Labs in a report on Tuesday, May 19th. Finally, Susquehanna upped their price objective on shares of Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a research note on Friday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $333.00.
Astera Labs Stock Down 2.6%
Astera Labs stock opened at $277.53 on Tuesday. The firm has a market cap of $48.15 billion, a P/E ratio of 137.39 and a beta of 3.84. The business has a fifty day moving average of $350.46 and a two-hundred day moving average of $246.41. Astera Labs, Inc. has a twelve month low of $97.89 and a twelve month high of $499.48.
Astera Labs (NASDAQ:ALAB – Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping the consensus estimate of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. During the same period in the previous year, the company posted $0.44 EPS. The business’s revenue for the quarter was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities analysts expect that Astera Labs, Inc. will post 2.7 earnings per share for the current year.
Insider Transactions at Astera Labs
In related news, COO Sanjay Gajendra sold 90,630 shares of the stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the sale, the chief operating officer owned 1,119,038 shares of the company’s stock, valued at $380,864,583.30. This represents a 7.49% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Jitendra Mohan sold 90,630 shares of the firm’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the sale, the chief executive officer owned 1,266,665 shares of the company’s stock, valued at approximately $431,109,432.75. This trade represents a 6.68% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders have sold 419,244 shares of company stock worth $163,135,169. 10.40% of the stock is owned by corporate insiders.
About Astera Labs
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Stories
- Five stocks we like better than Astera Labs
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
